|
"Mechanisms of Damage-Induced Homologous Recombination"
|
5R01CA079827-08
|
$240,133
|
SAMSON, LEONA
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
|
5R01CA129484-03
|
$393,213
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
|
A Model for Preclinical Biomarker Discovery in Pancreatic Ductal Adenocarcinoma
|
1K08CA137153-01A2
|
$163,080
|
Collisson, Eric
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
A new curcumin analogue with potent suppressive activity in pancreatic cancer
|
5R03CA137479-02
|
$76,320
|
LIN, JIAYUH
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
A Novel ROS Controlling Kinase
|
1R21CA135164-01A2
|
$206,190
|
FRIEDMAN, EILEEN
|
UPSTATE MEDICAL UNIVERSITY
|
|
A primary human xenograft model of pancreatic cancer.
|
5R03CA141245-02
|
$75,750
|
BAUER, TODD
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196 03152
|
$1,684,362
|
Schatzkin, Arthur
|
DCEG (NCI)
|
|
Academic Training in Medical Oncology
|
5T32CA009297-27
|
$304,451
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
ACOSOG Non Competing Renewal
|
5U10CA076001-14
|
$3,560,232
|
OTA, DAVID
|
DUKE UNIVERSITY
|
|
AKT Function in Pancreatic Tumor Cell Invasiveness and In Vivo Pathogenesis.
|
7R21CA129302-02
|
$208,628
|
Altomare, Deborah
|
UNIVERSITY OF CENTRAL FLORIDA
|
|
Allergies and pancreatic cancer: A pooled analysis in PANC4
|
5R03CA141570-02
|
$94,800
|
OLSON, SARA
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Amplification of tumor hypoxic responses by MIF-dependent HIF stabilization
|
5R01CA129967-02
|
$307,100
|
MITCHELL, ROBERT
|
UNIVERSITY OF LOUISVILLE
|
|
An integrative approach to cancer gene discovery in hepatocellular carcinoma
|
5R01CA124648-04
|
$435,804
|
POWERS, SCOTT
|
COLD SPRING HARBOR LABORATORY
|
|
Analysis of Patient Tumor Responses to Apo2L/TRAIL
|
5R01CA108888-05
|
$309,799
|
REPASKY, ELIZABETH
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Analysis of the p53 in vivo using a unique mouse model
|
5R01CA100193-08
|
$345,666
|
EVAN, GERARD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Animal model of Pancreatic Cancer
|
ZIA BC 011186
|
$285,491
|
Hussain, S. Perwez
|
CCR (NCI)
|
|
Anti-tumor Activity of Sugar Analogs via Blocking Glycolysis vs Glycosylation
|
5R01CA037109-21
|
$343,254
|
LAMPIDIS, THEODORE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Anti-Tumor Mechanisms and Therapeutic Effects of Vitamin D
|
5R01CA067267-16
|
$431,016
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Are shared controls useful in genome-wide association studies for cancer genetic
|
5R03CA141524-02
|
$94,800
|
Klein, Robert
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S1
|
$100,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S2
|
$143,893
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-32S3
|
$100,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-32
|
$4,161,905
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Aspects of MUC13 Mucin in Cancer
|
1R01CA142736-01A1
|
$329,906
|
Chauhan, Subhash
|
SANFORD RESEARCH/USD
|
|
Assessing pancreatic cancer susceptibility to ceramide-mediated cell death.
|
1R21CA143755-01
|
$246,123
|
Cabot, Myles
|
JOHN WAYNE CANCER INSTITUTE
|
|
Asymmetric Division and Self Renewal of Cancer Stem Cells
|
ZIA BC 011003
|
$198,294
|
Avital, Itzhak
|
CCR (NCI)
|
|
ATBC Study
|
ZIA CP010195 03031
|
$853,810
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
ATDC Function in Human Pancreatic Adenocarcinoma
|
5R01CA131045-03
|
$318,188
|
SIMEONE, DIANE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Aurora A kinase regulation of RalGEF/Ral GTPase signaling in pancreatic cancer
|
5F32CA138142-02
|
$39,548
|
Kidd, Ambrose
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Aurora Kinases as Therapeutic Targets in Pancreatic Cancer
|
5R01CA095031-09
|
$316,242
|
VON HOFF, DANIEL
|
TRANSLATIONAL GENOMICS RESEARCH INST
|
|
Autoantibodies Against Glycopeptide Epitopes as Serum Biomarkers of Cancer
|
5U01CA128437-04
|
$284,750
|
HOLLINGSWORTH, MICHAEL
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm
|
5R01CA132734-03
|
$313,533
|
Vile, Richard
|
MAYO CLINIC
|
|
B7-H3 in prognosis and immunotherapy of pancreatic cancer
|
5R03CA141086-02
|
$79,265
|
Wang, Xinhui
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Basis for Lymphomagenesis in Akt2 Transgenic Mice
|
5R01CA077429-11
|
$452,084
|
TESTA, JOSEPH
|
FOX CHASE CANCER CENTER
|
|
Baylor College of Medicine Cancer Center
|
2P30CA125123-04
|
$3,089,219
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S6
|
$100,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-04S1
|
$250,400
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$771,635
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biochemical and Molecular Studies on DT Diaphorase
|
5R01CA051210-20
|
$323,378
|
ROSS, DAVID
|
UNIVERSITY OF COLORADO DENVER
|
|
Biological Activity of Ras Oncogenes
|
2R01CA042978-24A1
|
$176,966
|
DER, CHANNING
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Biology and Immunology of Pancreatic Cancer Stem Cells in a Novel Mouse Model
|
5U01CA141468-02
|
$492,416
|
ENGLEMAN, EDGAR G.
|
STANFORD UNIVERSITY
|
|
Biomarker Reference Laboratory, EDRN
|
3U24CA086359-10S1
|
$150,022
|
GRIZZLE, WILLIAM
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$10,002
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Biomarkers for the Early Detection of Pancreatic Cancer
|
2U01CA111302-06
|
$616,200
|
KILLARY, ANN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Black/White PHS Study
|
ZIA CP010182 00430
|
$76,195
|
Silverman, Debra
|
DCEG (NCI)
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
ZIA BC 011004
|
$297,441
|
Avital, Itzhak
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,188,980
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Camptothecin Analogs for Cancer Therapy
|
2R44CA125871-02
|
$444,873
|
MORGAN, Lee
|
DEKK-TEC, INC.
|
|
Cancer Center Core Support Grant
|
3P30CA016086-34S4
|
$6,545,448
|
EARP, HENRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Core Support Grant
|
3P30CA016086-34S5
|
$99,753
|
EARP, HENRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|